List of Azura Ophthalmics patents

List of Azura Ophthalmics patents

List of Swatch patents

List of Central China Normal University patents

List of NeuroSky patents

List of food & beverage companies

List of companies in Stout Street Capital's investment portfolio

Patents where

Current Assignee

Name

is

Azura Ophthalmics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11634411 Compounds and methods for the treatment of ocular disorders	Patent 11634411 was granted and assigned to Azura Ophthalmics on April, 2023 by the United States Patent and Trademark Office.	Azura Ophthalmics	Azura Ophthalmics		United States Patent and Trademark Office	11634411	April 25, 2023
	‌ US Patent 10588915 Compositions and methods for the treatment of meibomian gland dysfunction	Patent 10588915 was granted and assigned to Azura Ophthalmics on March, 2020 by the United States Patent and Trademark Office.	Azura Ophthalmics	Azura Ophthalmics		United States Patent and Trademark Office	10588915	March 17, 2020
	‌ US Patent 11633410 Compositions and methods for the treatment of meibomian gland dysfunction	Patent 11633410 was granted and assigned to Azura Ophthalmics on April, 2023 by the United States Patent and Trademark Office.	Azura Ophthalmics	Azura Ophthalmics		United States Patent and Trademark Office	11633410	April 25, 2023
	‌ US Patent 11013749 Compositions and methods for the treatment of meibomian gland dysfunction	Patent 11013749 was granted and assigned to Azura Ophthalmics on May, 2021 by the United States Patent and Trademark Office.	Azura Ophthalmics	Azura Ophthalmics		United States Patent and Trademark Office	11013749	May 25, 2021
	‌ US Patent 11643429 Compounds and methods for the treatment of ocular disorders	Patent 11643429 was granted and assigned to Azura Ophthalmics on May, 2023 by the United States Patent and Trademark Office.	Azura Ophthalmics	Azura Ophthalmics		United States Patent and Trademark Office	11643429	May 9, 2023
	‌ US Patent 11459351 Compounds and methods for the treatment of ocular disorders		Azura Ophthalmics	Azura Ophthalmics		United States Patent and Trademark Office	11459351	October 4, 2022
	‌ US Patent 11324775 Compositions and methods for the treatment of contact lens discomfort	Patent 11324775 was granted and assigned to Azura Ophthalmics on May, 2022 by the United States Patent and Trademark Office.	Azura Ophthalmics	Azura Ophthalmics		United States Patent and Trademark Office	11324775	May 10, 2022
	‌ US Patent 11040062 Selenium disulfide compositions for use in treating meibomian gland dysfunction	Patent 11040062 was granted and assigned to Azura Ophthalmics on June, 2021 by the United States Patent and Trademark Office.	Azura Ophthalmics	Azura Ophthalmics		United States Patent and Trademark Office	11040062	June 22, 2021
	‌ US Patent 11517586 Instructions for composition and sensitivity		Azura Ophthalmics	Azura Ophthalmics		United States Patent and Trademark Office	11517586	December 6, 2022
	‌ US Patent 11484516 Agents for increasing meibomian gland lipid secretion	Patent 11484516 was granted and assigned to Azura Ophthalmics on November, 2022 by the United States Patent and Trademark Office.	Azura Ophthalmics	Azura Ophthalmics		United States Patent and Trademark Office	11484516	November 1, 2022
	‌ US Patent 10688122 Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion	Patent 10688122 was granted and assigned to Azura Ophthalmics on June, 2020 by the United States Patent and Trademark Office.	Azura Ophthalmics	Azura Ophthalmics		United States Patent and Trademark Office	10688122	June 23, 2020
	‌ US Patent 10772899 Compositions and methods for the treatment of meibomian gland dysfunction	Patent 10772899 was granted and assigned to Azura Ophthalmics on September, 2020 by the United States Patent and Trademark Office.	Azura Ophthalmics	Azura Ophthalmics		United States Patent and Trademark Office	10772899	September 15, 2020
	‌ US Patent 10875845 Compounds and methods for the treatment of ocular disorders	Patent 10875845 was granted and assigned to Azura Ophthalmics on December, 2020 by the United States Patent and Trademark Office.	Azura Ophthalmics	Azura Ophthalmics		United States Patent and Trademark Office	10875845	December 29, 2020

13 results

0 selected

13 results

0 selected